Copyright Reports & Markets. All rights reserved.

Global Fluoropolymer in Healthcare Market Insights, Forecast to 2025

Buy now

Table of Contents

    Global Fluoropolymer in Healthcare Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Fluoropolymer in Healthcare Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Fluoropolymer in Healthcare Market Size Growth Rate by Type
        • 1.4.2 Polytetrafluoroethylene (PTFE)
        • 1.4.3 Polyvinylidene Difluoride (PVDF)
        • 1.4.4 Fluorinated Ethylene Propylene (FEP)
        • 1.4.5 Ethylene Tetrafluoroethylene (ETFE)
        • 1.4.6 Polyvinyl Fluoride (PVF)
        • 1.4.7 Others
      • 1.5 Market by Application
        • 1.5.1 Global Fluoropolymer in Healthcare Market Size Growth Rate by Application
        • 1.5.2 Pharmaceutical Packaging
        • 1.5.3 Medical Devices
        • 1.5.4 Drug Delivery
        • 1.5.5 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Fluoropolymer in Healthcare Production
        • 2.1.1 Global Fluoropolymer in Healthcare Revenue 2014-2025
        • 2.1.2 Global Fluoropolymer in Healthcare Production 2014-2025
        • 2.1.3 Global Fluoropolymer in Healthcare Capacity 2014-2025
        • 2.1.4 Global Fluoropolymer in Healthcare Marketing Pricing and Trends
      • 2.2 Fluoropolymer in Healthcare Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Fluoropolymer in Healthcare Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Fluoropolymer in Healthcare Production by Manufacturers
        • 3.1.1 Fluoropolymer in Healthcare Production by Manufacturers
        • 3.1.2 Fluoropolymer in Healthcare Production Market Share by Manufacturers
      • 3.2 Fluoropolymer in Healthcare Revenue by Manufacturers
        • 3.2.1 Fluoropolymer in Healthcare Revenue by Manufacturers (2014-2019)
        • 3.2.2 Fluoropolymer in Healthcare Revenue Share by Manufacturers (2014-2019)
      • 3.3 Fluoropolymer in Healthcare Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Fluoropolymer in Healthcare Production by Regions

      • 4.1 Global Fluoropolymer in Healthcare Production by Regions
        • 4.1.1 Global Fluoropolymer in Healthcare Production Market Share by Regions
        • 4.1.2 Global Fluoropolymer in Healthcare Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Fluoropolymer in Healthcare Production
        • 4.2.2 United States Fluoropolymer in Healthcare Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Fluoropolymer in Healthcare Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Fluoropolymer in Healthcare Production
        • 4.3.2 Europe Fluoropolymer in Healthcare Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Fluoropolymer in Healthcare Import & Export
      • 4.4 China
        • 4.4.1 China Fluoropolymer in Healthcare Production
        • 4.4.2 China Fluoropolymer in Healthcare Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Fluoropolymer in Healthcare Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Fluoropolymer in Healthcare Production
        • 4.5.2 Japan Fluoropolymer in Healthcare Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Fluoropolymer in Healthcare Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Fluoropolymer in Healthcare Consumption by Regions

      • 5.1 Global Fluoropolymer in Healthcare Consumption by Regions
        • 5.1.1 Global Fluoropolymer in Healthcare Consumption by Regions
        • 5.1.2 Global Fluoropolymer in Healthcare Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Fluoropolymer in Healthcare Consumption by Application
        • 5.2.2 North America Fluoropolymer in Healthcare Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Fluoropolymer in Healthcare Consumption by Application
        • 5.3.2 Europe Fluoropolymer in Healthcare Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Fluoropolymer in Healthcare Consumption by Application
        • 5.4.2 Asia Pacific Fluoropolymer in Healthcare Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Fluoropolymer in Healthcare Consumption by Application
        • 5.5.2 Central & South America Fluoropolymer in Healthcare Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Fluoropolymer in Healthcare Consumption by Application
        • 5.6.2 Middle East and Africa Fluoropolymer in Healthcare Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Fluoropolymer in Healthcare Breakdown Dada by Type
      • 6.2 Global Fluoropolymer in Healthcare Revenue by Type
      • 6.3 Fluoropolymer in Healthcare Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Fluoropolymer in Healthcare Breakdown Dada by Application
        • 7.2.1 Global Fluoropolymer in Healthcare Consumption by Application
        • 7.2.2 Global Fluoropolymer in Healthcare Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Ashai Glass
        • 8.1.1 Ashai Glass Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.1.4 Fluoropolymer in Healthcare Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Chemours Company
        • 8.2.1 Chemours Company Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.2.4 Fluoropolymer in Healthcare Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Daikin industry
        • 8.3.1 Daikin industry Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.3.4 Fluoropolymer in Healthcare Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 3M (Dyneon)
        • 8.4.1 3M (Dyneon) Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.4.4 Fluoropolymer in Healthcare Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 Arkema
        • 8.5.1 Arkema Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.5.4 Fluoropolymer in Healthcare Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Daikin industry
        • 8.6.1 Daikin industry Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.6.4 Fluoropolymer in Healthcare Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Honeywell International
        • 8.7.1 Honeywell International Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.7.4 Fluoropolymer in Healthcare Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Dongyue Group
        • 8.8.1 Dongyue Group Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.8.4 Fluoropolymer in Healthcare Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Chicago Gasket
        • 8.9.1 Chicago Gasket Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.9.4 Fluoropolymer in Healthcare Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 Flontech USA
        • 8.10.1 Flontech USA Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Fluoropolymer in Healthcare
        • 8.10.4 Fluoropolymer in Healthcare Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 Solvay
      • 8.12 Saint-Gobain
      • 8.13 Mexichem
      • 8.14 Zeus Industrial Products
      • 8.15 W.L. Gore & Associates

      9 Production Forecasts

      • 9.1 Fluoropolymer in Healthcare Production and Revenue Forecast
        • 9.1.1 Global Fluoropolymer in Healthcare Production Forecast 2019-2025
        • 9.1.2 Global Fluoropolymer in Healthcare Revenue Forecast 2019-2025
      • 9.2 Fluoropolymer in Healthcare Production and Revenue Forecast by Regions
        • 9.2.1 Global Fluoropolymer in Healthcare Revenue Forecast by Regions
        • 9.2.2 Global Fluoropolymer in Healthcare Production Forecast by Regions
      • 9.3 Fluoropolymer in Healthcare Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Fluoropolymer in Healthcare Production Forecast by Type
        • 9.4.2 Global Fluoropolymer in Healthcare Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Fluoropolymer in Healthcare Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Fluoropolymer in Healthcare Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Fluoropolymer in Healthcare Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Fluoropolymer in Healthcare Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Fluoropolymer in Healthcare Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Fluoropolymer in Healthcare Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Fluoropolymer in Healthcare Upstream Market
        • 11.1.1 Fluoropolymer in Healthcare Key Raw Material
        • 11.1.2 Typical Suppliers of Key Fluoropolymer in Healthcare Raw Material
        • 11.1.3 Fluoropolymer in Healthcare Raw Material Market Concentration Rate
      • 11.2 Fluoropolymer in Healthcare Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Fluoropolymer in Healthcare Distributors
      • 11.5 Fluoropolymer in Healthcare Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Fluoropolymers are fluorocarbon-based polymers formed by a strong bonding between carbon and fluorine, which makes them mechanically stable. They are high-performance plastics and are characterized by high resistance to acids, bases, and solvents. Various fluoropolymer products such as polytetrafluoroethylene (PTFE), polyvinylidene difluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polychlorotrifluoroethylene (PCTFE), polyvinyl fluoride (PVF), ethylene chlorotrifluoroethylene (ECTFE), perfluoroalkoxy (PFA), and fluoroelastomers are commonly used in healthcare application.
        The pharmaceutical packaging segment accounted for major shares of the fluoropolymer market. Fluoropolymers are widely used in the packaging of pharmaceutical products such as medical liquids, tablets, pills, and sprays. The enhanced moisture barrier properties of fluoropolymers make them suitable for the blister packaging of sensitive pharmaceutical products such as pills and powders.
        PTFE is a synthetic polymer of tetrafluoroethylene (TFE). It is flame-resistant, strong, self-lubricating, hydrophobic, non-reactive, and non-stick. The fluoropolymer market in healthcare industry will continue to grow in the PTFE segment because it is extensively in the healthcare sector in packaging, medical devices, and biological membranes.
        Global Fluoropolymer in Healthcare market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Fluoropolymer in Healthcare.

        This report researches the worldwide Fluoropolymer in Healthcare market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
        This study categorizes the global Fluoropolymer in Healthcare breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Ashai Glass
        Chemours Company
        Daikin industry
        3M (Dyneon)
        Arkema
        Daikin industry
        Honeywell International
        Dongyue Group
        Chicago Gasket
        Flontech USA
        Solvay
        Saint-Gobain
        Mexichem
        Zeus Industrial Products
        W.L. Gore & Associates

        Fluoropolymer in Healthcare Breakdown Data by Type
        Polytetrafluoroethylene (PTFE)
        Polyvinylidene Difluoride (PVDF)
        Fluorinated Ethylene Propylene (FEP)
        Ethylene Tetrafluoroethylene (ETFE)
        Polyvinyl Fluoride (PVF)
        Others
        Fluoropolymer in Healthcare Breakdown Data by Application
        Pharmaceutical Packaging
        Medical Devices
        Drug Delivery
        Others

        Fluoropolymer in Healthcare Production Breakdown Data by Region
        United States
        Europe
        China
        Japan
        Other Regions

        Fluoropolymer in Healthcare Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Rest of South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

        The study objectives are:
        To analyze and research the global Fluoropolymer in Healthcare capacity, production, value, consumption, status and forecast;
        To focus on the key Fluoropolymer in Healthcare manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Fluoropolymer in Healthcare :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Buy now